Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionIeq Capital, Llc
Latest Disclosed Ownership22,871 shares
Latest Disclosed Value $ 7,567,428
Ieq Capital, Llc reports 64.76% decrease in ownership of DUL / Alnylam Pharmaceuticals, Inc.

On May 14, 2026 - Ieq Capital, Llc filed a 13F-HR form disclosing ownership of 22,871 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $6,534,245 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 64,905 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -64.76% during the quarter. The current value of the position is $5,957,896 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 22,871 -42,034 -64.76 7,567 -70.68 0.0255
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 64,905 2,728 4.39 25,810 -8.97 0.0773
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 62,177 56,055 915.63 28,353 1,320.44 0.0861
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,122 -37,892 -86.09 1,996 -83.20 0.0122
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 44,014 5,208 13.42 11,885 30.15 0.0945
2025-02-03 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 38,806 34,613 825.49 9,131 691.93 0.0883
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,193 1,153 37.93 1,153 56.23 0.0141
2024-08-12 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,040 1,550 104.03 739 232.43 0.0099
2024-05-09 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,490 1,490 223 0.0032
2024-02-07 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,540 -100.00 0 -100.00
2023-11-06 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,540 41 2.74 273 -4.23 0.0055
2023-08-08 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,499 194 14.87 285 8.81 0.0057
2023-05-02 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,305 -142 -9.81 261 -23.91 0.0061
2023-02-06 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,447 55 3.95 344 22.94 0.0096
2022-11-04 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,392 1,392 279 0.0077
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.